Cutting edge: Selective up-regulation of chemokine receptors CCR4 and CCR8 upon activation of polarized human type 2 Th cells by D. D&apos et al.
of June 4, 2019.
This information is current as
Cells
Activation of Polarized Human Type 2 Th
Chemokine Receptors CCR4 and CCR8 upon 
Cutting Edge: Selective Up-Regulation of
Francesco Sinigaglia
Daniela Mazzeo, Silvano Sozzani, Alberto Mantovani and 
Daniele D'Ambrosio, Andrea Iellem, Raffaella Bonecchi,
http://www.jimmunol.org/content/161/10/5111
1998; 161:5111-5115; ;J Immunol 
References
http://www.jimmunol.org/content/161/10/5111.full#ref-list-1
, 21 of which you can access for free at: cites 36 articlesThis article 
        average*
   
 4 weeks from acceptance to publicationFast Publication! •  
   
 Every submission reviewed by practicing scientistsNo Triage! •  
   
 from submission to initial decisionRapid Reviews! 30 days* •  
   
Submit online. ?The JIWhy 
Subscription
http://jimmunol.org/subscription
 is online at: The Journal of ImmunologyInformation about subscribing to 
Permissions
http://www.aai.org/About/Publications/JI/copyright.html
Submit copyright permission requests at: 
Email Alerts
http://jimmunol.org/alerts
Receive free email-alerts when new articles cite this article. Sign up at: 
Print ISSN: 0022-1767 Online ISSN: 1550-6606. 
Immunologists All rights reserved.
Copyright © 1998 by The American Association of
1451 Rockville Pike, Suite 650, Rockville, MD 20852
The American Association of Immunologists, Inc.,
 is published twice each month byThe Journal of Immunology
 by guest on June 4, 2019
http://w
w
w
.jimmunol.org/
D
ow
nloaded from
 
 by guest on June 4, 2019
http://w
w
w
.jimmunol.org/
D
ow
nloaded from
 
Cutting Edge: Selective Up-Regulation
of Chemokine Receptors CCR4 and
CCR8 upon Activation of Polarized
Human Type 2 Th Cells1
Daniele D’Ambrosio,2* Andrea Iellem,*
Raffaella Bonecchi,† Daniela Mazzeo,*
Silvano Sozzani,† Alberto Mantovani,† and
Francesco Sinigaglia*
Polarized Th1 and Th2 cells differentially express adhesion mol-
ecules and chemokine receptors, endowing these cells with dis-
tinct tissue homing capabilities. Here we report that, in contrast
to other chemokine receptors, the expression of CCR4 and CCR8
on Th2 cells is transiently increased following TCR and CD28
engagement. IL-4 is not required for this activation-induced up-
regulation of CCR4 and CCR8. In accordance with receptor ex-
pression, the response of Th2 cells to I-309 (CCR8 ligand) and
thymus- and activation-regulated chemokine (CCR4 and CCR8
ligand) is enhanced upon activation. Moreover, activated Th1
cells up-regulate CCR4 expression and functional responsiveness
to thymus- and activation-regulated chemokine. Analysis of po-
larized subsets of CD81 T cells reveals a similar pattern of che-
mokine receptor expression and modulation of responsiveness.
Taken together, these findings suggest that an up-regulation of
CCR4 and CCR8 following Ag encounter may contribute to the
proper positioning of activated T cells within sites of antigenic
challenge and/or specialized areas of lymphoid tissues. The
Journal of Immunology, 1998, 161: 5111–5115.
T he differentiation process of CD41 T cells proceeds alongtwo distinct pathways leading to the generation of polar-ized effector Th cells (1–3). IFN-g-producing Th1 cells
promote phagocyte-dependent immunity (4, 5). Th2 cells secreting
IL-4 and IL-5 promote IgE production and allergic responses (6).
Similar to the generation of CD41 Th1 and Th2 cells, naive CD81
T cells can differentiate into Th1 type 1 cytotoxic CD81 T cells
(Tc1)3 cells or Tc2 type cytotoxic CD81 T cells (7).
A multistep process mediated by the interplay of adhesion mol-
ecules and chemokines that involves rolling, firm adhesion, and
diapedesis results in the extravasation of immune effector cells
within peripheral tissues (8, 9). Recent findings indicate that P- and
E-selectin ligands (10) and chemokine receptors (11, 12) are dif-
ferentially expressed on Th1 and Th2 cells, providing these cells
with distinct tissue-homing abilities (13). Chemokines are mem-
bers of a large family of small cytokines that play a key role in the
leukocyte-recruitment process (14–16). We and others have re-
ported recently that among eight CC and four CXC chemokine
receptors, Th1 cells predominantly express CXCR3 and CCR5
(12, 17, 18); Th2 cells selectively express CCR3 (11), CCR4 (12,
17), and CCR8 (19). Although these findings suggest that different
chemotactic signals are required for extravasation, migration, and
tissue homing, the hierarchy and composition of these signals are
unknown and may depend upon the chemokines present in the
tissue and the chemokine receptors expressed on the invading
cells.
Here, we investigated the effect of Ag receptor triggering on the
expression pattern of chemokine receptors on Th1 and Th2 cells.
Our data indicate that, in contrast to other chemokine receptors, the
expression of CCR4 and CCR8 on Th2 cells and CCR4 on Th1
cells is markedly increased upon activation. These findings suggest
a unique role for these receptors in extravasation, tissue migration,
and the positioning of effector T cells.
Materials and Methods
Type 1 and type 2 lines and Th2 cell clones
Type 1 and type 2 cell lines were generated from cord blood lympho-
cytes and maintained in culture as described previously (20). CD41 Th1
and Th2 cells and CD81 Tc1 and Tc2 cells were purified by immuno-
magnetic negative selection using anti-CD4 or anti-CD8 mAb-coated
microbeads according to the manufacturer’s instructions (Miltenyi Bio-
tec, Bergisch Gladbach, Germany). The Lolium perenne group-1-spe-
cific Th2 clone D4.11, which was obtained as described previously (12),
was restimulated with PHA and irradiated PBMCs and cultured in com-
plete medium with IL-2.
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Northern blot analysis
For Northern blots, total RNA was extracted from polarized CD41 or
CD81 T cells by TRIzol (Life Technologies, Grand Island, NY). For ac-
tivation experiments, purified CD41 Th1 and Th2 cells were either left
untreated or incubated for 16–24 h on anti-CD3 (Tr66 mAb)-coated plates
with 1 mg/ml of anti-CD28 mAb (PharMingen, San Diego, CA). The Th2
clone D4.11 was either left untreated or incubated for 24 h on anti-CD3-
coated plates with 1 mg/ml of anti-CD28 mAb. TCR triggering was ter-
minated by washing and culturing the cells in complete medium with IL-2.
Untreated and TCR-stimulated cells were lysed at various times after the
termination of TCR-triggering. Total RNA was extracted, and equal
amounts of RNA (10 mg/lane) were fractionated on a 1% agarose-formal-
dehyde gel. The specific mRNAs were detected by the hybridization of
nylon membranes (NorthernMax Kit, Ambion, Austin, TX) with 32P-la-
beled DNA probes for human CCR3, CCR4, CCR5, CCR8, and CXCR3
according to the manufacturer’s instructions (NorthernMax Kit, Ambion).
The filters were exposed to X-OMAT AR film (Eastman Kodak, Rochester,
NY) between double intensifying screens (DuPont, San Diego, CA) at
270°C. The extent of the hybridization was quantified by densitometric
analysis with the entry level image system (Immagini e computer, Milan,
Italy), and the values were normalized using the glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH) signal as a reference.
Analysis of intracellular calcium mobilization
Type 1 and type 2 polarized T cells were either left untreated or activated
as described above. Next, cells were washed and rested by incubation in
complete medium with IL-2 for 12 h. Fluo-3/acetoxymethyl ester (AM)
loading (21) was performed by incubating the cells (5 3 106/ml) in buffer
A (HBSS with 10 mM HEPES) with 2 mM fluo-3/AM (Molecular Probes,
Eugene, OR) at 37°C for 30 min. The incubation was prolonged by 30 min
after the addition of an equal volume of buffer B (HBSS with 10 mM
HEPES and 5% FCS). Cells were washed twice in buffer B and stained
with quantum red-conjugated anti-CD4 or anti-CD8 Abs (Sigma, St. Louis,
MO). Cells were washed, resuspended at 2 3 106/ml, and analyzed by
FACS. Emissions at 525 and 613 nm were measured on a log scale before
and after stimulation with the chemokines (IFN-inducible protein-10 (IP-
10), eotaxin, I-309, and thymus- and activation-regulated chemokine
(TARC) were purchased from R&D Systems, Minneapolis, MN). Analysis
was restricted to CD41 or CD81 T cells by gating on FL31 cells, with an
acquisition of 3000 events.
Results and Discussion
To study the regulation of chemokine receptor expression on Th
cells, we generated T cell lines from leukocytes isolated from cord
blood as described previously (20). The Th phenotype of CD41
and CD81 T cells was determined by restimulation and intracel-
lular staining for IFN-g and IL-4 production (data not shown).
Purified CD41 Th1 or Th2 cells were either left in culture with
FIGURE 1. Activation-dependent regulation of chemokine receptor ex-
pression in Th1 and Th2 cells. A, Th1 and Th2 cells were either left un-
treated or cultured on anti-CD3 mAb-coated plates with soluble anti-CD28
mAb. Cells were harvested, and total RNA was extracted. A total of 10 mg
of total RNA was subsequently used in Northern blot analysis. Filters were
hybridized with 32P-labeled probes for CXCR3, CCR3, CCR4, and CCR8.
Equivalent loading of RNA was verified by ethidium bromide staining of
18S and 28S ribosomal RNA. B, Th2 cells were either left untreated or
cultured on anti-CD3 mAb-coated plates with soluble anti-CD28 mAb in
the presence or absence of anti-IL-4 mAb (500 ng/ml). A total of 10 mg of
total RNA was subsequently used in Northern blot analysis. Filters were
hybridized with 32P-labeled probes for CCR4, CCR8, and GAPDH.
FIGURE 2. Chemokine-induced intracellular Ca21
mobilization in resting and activated Th1 and Th2 cells.
Th1 and Th2 cells were either left untreated or activated
as described in Fig. 1. Cells that had been loaded with
fluo-3/AMandstainedwithquantumred-conjugatedanti-
CD4 Abs were analyzed by flow cytometry by gating on
CD41 cells. Resting (dashed lines) and activated (solid
lines) Th1 and Th2 cells were stimulated with IP-10 (50
ng/ml), eotaxin (400 ng/ml), I-309 (200 ng/ml), and
TARC (10 ng/ml). The time of the addition of the che-
mokines is indicated by the arrow. The response is ex-
pressed as the fold increase of mean fluorescence inten-
sity at time 0 for emissions at 525 nm. One
representative experiment of five is shown.
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IL-2 or cultured on anti-CD3 mAb-coated plates with soluble anti-
CD28 mAb. Subsequently, the cells were lysed, and total RNA
was extracted and analyzed for CXCR3, CCR3, CCR4, and CCR8
mRNA expression. In agreement with recent reports (11, 12, 18,
19), CXCR3 is preferentially expressed on Th1 cells, whereas
CCR3, CCR4, and CCR8 are preferentially expressed on Th2 cells
(Fig. 1A). Stimulation with anti-CD3 and anti-CD28 Abs
down-regulates the mRNA expression of CXCR3 in Th1 cells and
CCR3 in Th2 cells (Fig. 1A). In contrast, CCR4 and, to a greater
extent, CCR8 transcripts are up-regulated in TCR-stimulated Th2
cells (Fig. 1A). In addition, CCR4 mRNA becomes detectable in
TCR-stimulated Th1 cells (Fig. 1A).
Since CCR4 and CCR8 are expressed on Th2 cells that have
been generated in vitro in the presence of IL-4, it is possible that
the IL-4 produced upon restimulation of Th2 cells is responsible
for the increased expression of CCR4 and CCR8. Therefore, we
performed the stimulation in the presence of anti-IL-4 blocking
Abs. This experiment shows that blocking IL-4 does not inhibit the
up-regulation of CCR4 and CCR8 upon activation of Th2 cells
(Fig. 1B). Moreover, the addition of exogenous IL-4 or superna-
tants obtained from activated Th2 cells does not result in an up-
regulation of CCR4 and/or CCR8 in Th1 cells or a further en-
hancement of these receptors in Th2 cells (data not shown).
To test the functional relevance of these observations, we ex-
plored chemokine responsiveness by measuring intracellular cal-
cium mobilization following activation of Th1 and Th2 cells. Con-
sistent with receptor expression, Th1 cells preferentially respond to
IP-10 (CXCR3 ligand (22)), whereas Th2 cells selectively respond
to eotaxin (CCR3 ligand (23)), I-309 (CCR8 ligand (24)), and
TARC (CCR4 and CCR8 ligand (25, 26)) (Fig. 2). Stimulation
with anti-CD3 and anti-CD28 Abs results in diminished responses
of Th1 cells to IP-10 (Fig. 2, upper left panel) and of Th2 cells to
eotaxin (Fig. 2, upper right panel). In contrast, the response to
TARC and, more markedly, to I-309 is increased upon activation
of Th2 cells (Fig. 2, middle and lower right panels), and the re-
sponse to TARC becomes detectable in activated Th1 cells (Fig. 2,
lower left panel).
Since the experiments described above were performed on po-
larized T cell lines obtained by a single cycle of stimulation, we
asked whether a T cell clone that had been subjected to repeated
cycles of stimulation would exhibit a similar pattern of CCR4 and
CCR8 regulation. TCR and CD28 triggering of a Th2 clone results
in a marked up-regulation of CCR4 and CCR8 (Fig. 3). In addition,
following termination of TCR triggering, the expression of CCR4
FIGURE 3. Transient up-regulation of CCR4 and CCR8 expression
upon activation of a Th2 clone. The Th2 clone D4.11 was either left un-
treated or activated as described in Fig. 1. A fraction of the cells was lysed
immediately (24 h). The remaining cells were washed, cultured, and har-
vested at 48, 72, and 96 h; total RNA was extracted. A total of 10 mg of
total RNA was subsequently used for Northern blot analysis. Filters were
hybridized with 32P-labeled probes for CCR4, CCR8, and GAPDH.
FIGURE 4. Chemokine receptor expression and
modulation of chemokine responsiveness in Tc1 and
Tc2 cells. A, A total of 10 mg of total RNA from Tc1
and Tc2 cells was used for Northern blot analysis. Fil-
ters were hybridized with 32P-labeled probes for
CXCR3, CCR3, CCR4, CCR5, and CCR8. A normal-
ized densitometric analysis of a representative exper-
iment is shown. B, Tc1 and Tc2 cells were either left
untreated or activated, loaded with fluo-3/AM, stained
with quantum red-conjugated anti-CD8 Abs, and ana-
lyzed by flow cytometry by gating on CD81 cells.
Resting (dashed lines) and activated (solid lines) Tc1
and Tc2 cells were stimulated with IP-10 (50 ng/ml),
eotaxin (400 ng/ml), I-309 (200 ng/ml), and TARC (10
ng/ml). The time of the addition of the chemokines is
indicated by the arrow. The response is expressed as
the fold increase of mean fluorescence intensity at time
0 for emissions at 525 nm. One representative exper-
iment of three is shown.
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and CCR8 returns to basal levels within 72 h (Fig. 3). Similar
findings were observed with cord blood-derived Th2 cells (data not
shown). These data indicate that Th2 cells transiently up-regulate
CCR4 and CCR8 upon activation via the TCR. Collectively, our
findings suggest that TCR-mediated activation of Th cells re-
sults in a transient alteration of the pattern of chemokine re-
ceptor expression.
Previous studies have demonstrated that, in addition to CD41 T
cells, type 1 and type 2 populations of CD81 T cells (Tc1 and Tc2
cells) can also be generated in vitro and isolated in vivo in immu-
nopathologic conditions (7, 27, 28). Thus, we have extended our
analysis of chemokine receptors to polarized Tc1 and Tc2 cells
generated from cord blood T cells. An analysis of the mRNA ex-
pression of several chemokine receptors revealed that, similar to
CD41 Th cells, Tc1 cells preferentially express CXCR3 and CCR5
(Fig. 4A); Tc2 cells selectively express CCR3, CCR4, and CCR8
(Fig. 4A). To verify the modulation of chemokine responsiveness
upon activation of polarized CD81 T cells, TCR- and CD28-stim-
ulated Tc1 and Tc2 cells were assayed for their ability to mobilize
calcium in response to various chemokines. The overall pattern of
calcium mobilization in response to chemokines is concordant
with the expression profile of chemokine receptors in Tc1 and Tc2
cells and is similar to Th1 and Th2 cells (Fig. 4B and data not
shown). The response of Tc1 cells to IP-10 is greatly reduced
following TCR-mediated activation (Fig. 4B). Activation of Tc2
cells results in a diminished response to eotaxin, whereas the re-
sponse to TARC and I-309 is increased (Fig. 4B). Taken together,
these data indicate that the pattern and regulation of chemokine
receptor expression of polarized subsets of CD81 T cells may
overlap that of CD41 T cells.
Recent studies have reported that TCR-mediated activation of T
cells results in a down-modulation of CCR1, CCR2, CCR3, CCR5,
and CXCR3 expression (11, 18, 29, 30). Our study reveals that, in
contrast to other receptors, CCR4 and, to a greater extent, CCR8
are up-regulated upon TCR-mediated activation of Th2 cells.
CXCR4 and CCR7 have been reported to be up-regulated upon
activation of T cells (31, 32). However, recent work established
that TCR triggering results in a down-modulation of CXCR4 that
is subsequently reinduced by the autocrine action of secreted IL-4
(33). Thus, CCR7 is the only other receptor to be up-regulated
upon TCR triggering (31). Interestingly, the CCR7 ligands, sec-
ondary lymphoid-tissue chemokine, and EBI1 ligand chemokine
have been proposed to control the initial entry of naive T cells and
the subsequent encounter of activated T and B cells in secondary
lymphoid tissues (34, 35). Notably, CCR7 is also up-regulated
upon activation of both Th1 and Th2 cells, suggesting a potential
contribution to their migration patterns (A.I. and D.D., unpub-
lished observations). Given their mode of regulation, CCR4 and
CCR8 may play a role similar to CCR7 in focusing activated T
cells to certain areas of lymphoid tissues. However, in contrast to
CCR7, CCR4 and particularly CCR8 are selectively expressed on
polarized effector Th2 cells, suggesting a unique function in lo-
calizing and positioning activated Th2 cells. It is noteworthy that
CCR4 and CCR8 share many common features. Their sequence is
highly homologous (36, 37); they are both highly expressed on
thymocytes, basophils, and Th2 cells (12, 19, 24, 36); and both are
receptors for TARC (26). Collectively, these data suggest that
CCR4 and CCR8 may play a critical role in localizing activated
Th2 cells within sites of antigenic challenge and/or to specialized
areas of lymphoid tissues.
Great attention has recently been placed on the possibility of
distinguishing Th1 vs Th2 cells on the basis of the differential
expression of chemokine receptors. Our findings suggest that
CCR8, which is highly expressed upon TCR-mediated activation,
may be a very useful and selective marker for the in situ identifi-
cation of recently activated Th2 cells.
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